SkinBioTherapeutics plc (AIM: SBTX) announced on 11/7/18 positive data from the first two elements of its human study which focus on skin irritancy and moisturisation potential.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,